Adicet

Adicet is a biotechnology company based in Menlo Park, California, dedicated to developing advanced gamma delta T cell therapies aimed at treating autoimmune diseases and cancer. With a focus on best-in-class therapies, Adicet leverages a proprietary cell platform to deliver innovative immune cell treatments that promise novel targeting and tissue homing capabilities.

The company is actively engaged in expanding its clinical pipeline and recently reported updates on its financial performance and ongoing initiatives. Adicet's leadership team and scientific advisory board drive the company's mission to harness the potential of gamma delta T cells in the field of immunotherapy.

Generated from the website